Relay Therapeutics, Inc. (RLAY) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 658.46M | 578.28M | 624.01M | 680.39M | 739.66M | 809.2M | 865.13M | 704.27M | 770.1M | 770.1M | 831.8M | 884.35M |
| Cash & Short-Term Investments | 204.59M | 554.52M | 596.43M | 656.77M | 710.36M | 781.32M | 839.61M | 688.41M | 749.61M | 750.09M | 810.62M | 871.57M |
| Cash Only | 204.59M | 84.02M | 91.56M | 113.94M | 93.54M | 124.29M | 152.36M | 134.13M | 152.87M | 143.74M | 151.33M | 145.9M |
| Short-Term Investments | 0 | 470.5M | 504.87M | 542.83M | 616.81M | 657.04M | 687.25M | 554.29M | 596.74M | 606.35M | 659.29M | 725.67M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 211K | 78K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | 0.53 | 2.03K |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 453.87M | 23.76M | 3.74M | 7.58M | 7.35M | 10.53M | 6.79M | 5.73M | 7.3M | 3.31M | 3.68M | 3.39M |
| Total Non-Current Assets | 41.15M | 43.05M | 45.99M | 48.45M | 59.7M | 62.09M | 64.99M | 68.28M | 71.34M | 73.88M | 75.16M | 77.67M |
| Property, Plant & Equipment | 39.81M | 41.72M | 43.73M | 46.19M | 55.28M | 57.67M | 60.57M | 63.27M | 66.33M | 68.87M | 70.15M | 72.66M |
| Fixed Asset Turnover | 0.07x | 0.16x | - | 0.01x | 0.14x | - | - | - | 0.15x | -0.00x | 0.35x | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M | 2.3M |
| Long-Term Investments | 0 | 1.34M | 0 | 0 | 0 | 0 | 2.12M | 2.71M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 1.34M | 0 | 2.26M | 2.26M | 2.12M | 2.12M | 0 | 2.71M | 2.71M | 2.71M | 2.71M | 2.71M |
| Total Assets | 699.61M | 621.33M | 670M | 728.84M | 799.36M | 871.3M | 930.12M | 772.55M | 841.44M | 843.98M | 906.96M | 962.02M |
| Asset Turnover | 0.00x | 0.01x | - | 0.00x | 0.01x | - | - | - | 0.01x | -0.00x | 0.03x | 0.00x |
| Asset Growth % | -12.48% | -28.69% | -27.97% | -5.66% | -5% | 3.24% | 2.55% | -19.69% | -18.9% | -23.26% | -22.4% | 8.16% |
| Total Current Liabilities | 29.75M | 25.58M | 32.6M | 32.52M | 37.05M | 50.73M | 46.97M | 45.04M | 37.14M | 30.27M | 50.75M | 71.58M |
| Accounts Payable | 4.1M | 7.71M | 2.75M | 5.18M | 8.45M | 14.1M | 6.87M | 11.17M | 7.97M | 9.21M | 13.35M | 14.78M |
| Days Payables Outstanding | - | 803.04 | - | - | - | - | - | - | - | - | 15.88 | 13.73 |
| Short-Term Debt | 3.89M | 3.77M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 7.68M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 21.76M | 14.11M | 1.08M | 609K | 1.68M | 2.1M | 1.36M | 768K | 1.66M | 1.2M | 1.12M | 25.28M |
| Current Ratio | 22.13x | 22.61x | 19.14x | 20.92x | 19.96x | 15.95x | 18.42x | 15.64x | 20.73x | 25.44x | 16.39x | 12.36x |
| Quick Ratio | 22.13x | 22.61x | 19.14x | 20.92x | 19.96x | 15.95x | 18.42x | 15.64x | 20.73x | 25.44x | 16.39x | 12.36x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 27.68M | 28.69M | 29.69M | 30.66M | 41.23M | 42.77M | 44.29M | 45.76M | 58.53M | 61.71M | 77.84M | 80.32M |
| Long-Term Debt | 27.68M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 28.69M | 29.69M | 30.66M | 41.23M | 42.77M | 44.29M | 45.76M | 47.16M | 48.5M | 49.81M | 51.1M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11.37M | 13.21M | 28.02M | 29.22M |
| Total Liabilities | 57.43M | 54.27M | 62.29M | 63.18M | 78.28M | 93.5M | 91.25M | 90.81M | 95.68M | 91.98M | 128.59M | 151.9M |
| Total Debt | 31.57M | 32.46M | 33.33M | 34.18M | 47.16M | 48.5M | 49.81M | 51.1M | 52.31M | 53.47M | 54.6M | 55.71M |
| Net Debt | -173.02M | -51.56M | -58.23M | -79.76M | -46.38M | -75.78M | -102.54M | -83.03M | -100.56M | -90.27M | -96.73M | -90.19M |
| Debt / Equity | 0.05x | 0.06x | 0.05x | 0.05x | 0.07x | 0.06x | 0.06x | 0.07x | 0.07x | 0.07x | 0.07x | 0.07x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 642.18M | 567.06M | 607.71M | 665.66M | 721.08M | 777.79M | 838.86M | 681.74M | 745.76M | 752M | 778.37M | 810.12M |
| Equity Growth % | -10.94% | -27.09% | -27.56% | -2.36% | -3.31% | 3.43% | 7.77% | -15.85% | -15.58% | -20.86% | -22.14% | 3.91% |
| Book Value per Share | 3.57 | 3.30 | 3.53 | 3.89 | 4.26 | 4.65 | 5.98 | 5.13 | 5.70 | 6.13 | 6.37 | 6.66 |
| Total Shareholders' Equity | 642.18M | 567.06M | 607.71M | 665.66M | 721.08M | 777.79M | 838.86M | 681.74M | 745.76M | 752M | 778.37M | 810.12M |
| Common Stock | 182K | 168K | 168K | 168K | 168K | 168K | 167K | 133K | 132K | 127K | 123K | 122K |
| Retained Earnings | -2.09B | -2.01B | -1.96B | -1.89B | -1.82B | -1.74B | -1.66B | -1.57B | -1.48B | -1.4B | -1.32B | -1.25B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -172K | 733K | 493K | -163K | 38K | -991K | 2.51M | -1.34M | -1.16M | -196K | -3.39M | -6.08M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |